In a business update published on Tuesday, Moderna (NASDAQ:MRNA) said that it's still on pace to deliver 100 million doses of its mRNA-1273 coronavirus vaccine to the U.S. federal government by the end of the first quarter (March 31). The company added that it should have a total of 200 million available by the conclusion of the following quarter (June 30).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,